he Effect of ScanCap Technology on Medication Adherence and Hypertension Outcomes

描述（由申请人提供）：在该II期SBIR项目中，Concordance Health Solutions（CHS）将继续开发ScanCap系统，并测试其对依从率和高血压患者结局的有效性。ScanCap系统是一种电子提醒帽，可在药房无缝编程，并纳入处方药的原始包装中。最终产品还将能够记录何时服用剂量，并将该信息报告给护理人员和医疗保健合作伙伴，以提高患者的药物依从性。II期研究的具体目标是：目标1：制造ScanCap并完成硬件和软件的开发，以收集存储在器械上的数据;目标2：确定与安慰剂帽相比，使用ScanCap是否可以改善药物依从性;目标3：确定与安慰剂帽相比，使用ScanCap是否可以改善血压控制。改善药物依从性是NIH几个研究所目前的重点领域，符合NIH延长健康生命和减少疾病和残疾负担的使命。该扫描帽的设计是制造约2美元/单位的大容量，包括一个无线接口，自动编程帽在药房;视觉和听觉提醒时，剂量是由于;和记录剂量的能力，并无线传输病人的药物记录到电子数据库。它体积小，易于携带，设计适用于标准处方药瓶和安全帽功能。未来的功能将包括与智能手机连接以进行实时提醒的能力。在第二阶段结束时，CHS将制造ScanCap电子提醒帽和数据收集系统的原型。CHS还将证明使用ScanCap系统的患者对药物依从性和血压控制的影响。适当地坚持处方药物治疗方案可以改善整体健康状况，并降低许多患者的医疗费用。然而，典型的药物依从率低于50%，原因有很多，既有故意的，也有无意的，比如健忘和混乱。现在市场上的提醒设备不能作为原始处方包装的一部分，让患者自己整理和实施柜台提醒产品。一个易于使用的提醒帽，适合标准处方瓶将给药剂师一个工具，以帮助他们的病人与药物剂量计划。将提醒设备集成到药房系统中将使患者对其使用产生信心，并最终导致采用率增加，从而导致更好的药物依从性和健康结果以及更低的医疗保健成本。

DESCRIPTION (provided by applicant): In this Phase II SBIR project, Concordance Health Solutions (CHS) will continue development of the ScanCap System and test its effectiveness on adherence rates and hypertension patient outcomes The ScanCap System is an electronic reminder cap that is seamlessly programmed at the pharmacy and incorporated into original packaging for prescription medications. The final product will also have the capability of recording when doses are taken and reporting that information back to caregivers and healthcare partners to improve patient medication adherence. The specific aims of the Phase II study are: Aim 1: Manufacture the ScanCap and complete development of the hardware and software to collect data stored on the device; Aim 2: Determine whether medication adherence can be improved through the use of the ScanCap compared with a placebo cap; and Aim 3: Determine whether BP control can be improved through use of the ScanCap compared with a placebo cap. Improving medication adherence is a current focus area of several NIH institutes and in line with the NIH mission to extend healthy life and reduce the burdens of illness and disability. The Scan Cap is designed to be manufactured for around $2/unit in high volumes and includes a wireless interface to automatically program the cap at the pharmacy; visual and audible reminders when a dose is due; and the ability to record doses taken and wirelessly transmit the patient medication record to an electronic database. It is small and easily portable with a design adaptable to standard prescription vials and safety cap features. Future features will include the ability to connect with a smart phone for real-time reminders. At the conclusion of Phase II, CHS will have manufactured the ScanCap electronic reminder cap and a prototype of the data collection system. CHS will also have demonstrated the effect of patients using the ScanCap system on medication adherence and blood pressure control. Proper adherence to prescription medication regimens is shown to improve overall health outcomes and reduce healthcare costs for many patients. However, typical medication adherence rates are less than 50 percent for a host of reasons that are both intentional in nature and unintentional, such as forgetfulness and confusion. Reminder devices on the market now are not available as part of the original prescription package, leaving the patient to sort through and implement over the counter reminder products on their own. An easy-to-use reminder cap that fits standard prescription vials will give pharmacists a tool to help their patients with medication dosing schedules. Integrating the reminder device into the pharmacy system will create patient confidence in its use and will ultimately result in increased adoption, leading to better medicatio adherence and health outcomes and lower healthcare costs.